NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 Recruiting
139 enrolled
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Recruiting
300 enrolled
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Phase 2 Recruiting
40 enrolled
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 Recruiting
48 enrolled
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/3 Recruiting
1,122 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
Musculoskeletal Cancers Remote Monitoring and Care
Phase NA Recruiting
60 enrolled
LUPARPED
Phase 1/2 Recruiting
25 enrolled
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 Recruiting
90 enrolled
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/2 Recruiting
289 enrolled
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/2 Recruiting
104 enrolled
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
Phase 1 Recruiting
18 enrolled
ISG Os2Oss
Recruiting
120 enrolled
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Phase 1 Recruiting
24 enrolled
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/2 Recruiting
56 enrolled
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase 2 Recruiting
45 enrolled
UFSR for OS
Recruiting
10 enrolled
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 Recruiting
60 enrolled
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/2 Recruiting
27 enrolled
AflacST2301
Phase 1 Recruiting
12 enrolled
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Phase 1 Recruiting
24 enrolled
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 Recruiting
62 enrolled
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/2 Recruiting
147 enrolled
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Phase 1/2 Recruiting
63 enrolled
REGOSTA
Phase NA Recruiting
168 enrolled
REGOMAIN
Phase 2 Recruiting
36 enrolled
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Phase 1 Recruiting
30 enrolled
Pediatric PET/MR Image Registry
Recruiting
100 enrolled
SPEARHEAD-3 Pediatric Study
Phase 1/2 Recruiting
20 enrolled
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Phase 1/2 Recruiting
55 enrolled
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Phase NA Recruiting
150 enrolled
GISAR
Recruiting
9,000 enrolled
PREMOST
Recruiting
40 enrolled
Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 Recruiting
41 enrolled
ADER
Recruiting
50 enrolled